Now Approved

Tivdak is a prescription medicine used to treat adults with cervical cancer

•  that has returned or has spread to other parts of the body, and
•  who have received chemotherapy that did not work or is no longer working

Tivdak was FDA-approved based on a clinical study that measured how many patients had a tumor response and how long that response lasted. There is another study with Tivdak to confirm the clinical benefit.

Now, you have another treatment option.

REVIEW THE IMPORTANT FACTS

Information and Resources


  • Eye Care Guide for Patients Icon

    Eye Care Guide for Patients

    A guide to caring for your eyes while on treatment

    Download

  • Eye Drop Tracker Icon

    Eye Drop Tracker

    An easy-to-use tracker to help you stay on top of your eye drop schedule

    download

  • Tivdak Wallet Card Icon

    Tivdak Wallet Card

    A convenient card you can carry to inform healthcare teams that you’re being treated with Tivdak

    download

  • Important Facts Icon

    Important Facts

    A summary of key information about Tivdak

    ENGLISHESPAÑOL

  • Tivdak Medication Guide Icon

    Medication Guide

    A quick guide to treatment with Tivdak

    download

TivdakTexts


TivdakTexts is a text message support program designed to help assist you throughout treatment
Some benefits of TivdakTexts include:

  • Appointment Reminders
  • Eye Drop Reminders
To sign up for TivdakTexts, follow these steps:

  • Mobile Phone

    Step 1:
    On your mobile phone, text the word JOIN to 74277

  • Step 2:
    When you get a message back from us, text back AGREE to confirm your participation in the support program

  • Step 3:
    Then answer 3 questions:

    • Your first name, so we can personalize messages
    • Your ZIP code, so we can set your time zone
    • The date you started or plan to start taking Tivdak
  • Message and data rates may apply. Check with your mobile service provider. Message frequency will be based on your selections. Text HELP for help with the program. Text STOP to stop receiving messages. See Terms of Use and Conditions.

    By initiating a text message, you agree to receive automated text messages from Seagen. You can unsubscribe at any time. You represent that you are the subscriber of the number provided and 18 or older. You must notify Seagen immediately if you relinquish the number provided. Consent is not required as a condition of purchasing any products or services.

Get Support


Seagen Secure® Patient Assistance Program Logo

Seagen Secure® is an access and reimbursement support program for people receiving or planning to receive Tivdak. Oncology Access Advocates are an all-in-one resource to help you and your caregiver with access-related questions throughout your treatment. Seagen Secure® can provide information regarding coverage, financial assistance, and referrals to outside organizations for additional support needs.

VISIT THE WEBSITE

Call 855-4SECURE (855-473-2873) for more or visit seagensecure.com for more information.

What is TIVDAK?

TIVDAK is a prescription medicine used to treat adults with cervical cancer:

  • that has returned or has spread to other parts of the body, and
  • who have received chemotherapy that did not work or is no longer working

TIVDAK was FDA-approved based on a clinical study that measured how many patients had a tumor response and how long that response lasted. There is another study with TIVDAK to confirm the clinical benefit.


IMPORTANT SAFETY INFORMATION

What is the most important information I should know about TIVDAK?

Eye problems are common with TIVDAK and can be serious. TIVDAK can cause changes to the surface of your eye that can lead to dry eyes, eye redness, eye irritation, corneal ulcers, blurred vision, and severe vision loss. Tell your healthcare provider if you develop new or worsening vision changes or eye problems during treatment.

Your healthcare provider will send you to an eye specialist to check your eyes before you start treatment with TIVDAK, before each dose of TIVDAK, and as needed for any new or worsening signs and symptoms of eye problems.

Your healthcare provider will prescribe 3 different types of eye drops before you start treatment with TIVDAK. Bring the eye drops with you to each infusion and use them as directed by your healthcare provider to reduce your risk of eye problems:

  • You should use steroid eye drops before each infusion and as prescribed for 72 hours after each infusion.
  • You should use vasoconstrictor eye drops right before each infusion.
  • You should use lubricating eye drops throughout treatment and for 30 days after your last dose of TIVDAK.

Do not wear contact lenses throughout your treatment with TIVDAK unless you are told to use them by your eye specialist.

What are the possible side effects of TIVDAK?

Serious side effects of TIVDAK may include:

Peripheral neuropathy (nerve problems) can occur with TIVDAK and can be serious. Tell your healthcare provider right away if you have new or worsening numbness or tingling in your hands or feet or muscle weakness.

Bleeding (hemorrhage) can occur with TIVDAK and can be serious. Tell your healthcare provider right away if you get signs or symptoms of bleeding during treatment with TIVDAK including blood in your stool or black stool (looks like tar), blood in your urine, cough up or vomit blood, unusual vaginal bleeding, any unusual or heavy bleeding.

Lung problems. TIVDAK may cause severe or life-threatening inflammation of the lungs that can lead to death. Tell your healthcare provider right away if you get new or worsening symptoms, including trouble breathing, shortness of breath, or cough.

The most common side effects of TIVDAK include:

  • Decreased red blood cell and white blood cell counts
  • Tiredness
  • Nausea
  • Numbness or tingling in your hands or feet, or muscle weakness (peripheral neuropathy)
  • Hair loss (alopecia)
  • Nosebleed (epistaxis)
  • Eye problems (conjunctival disorders)
  • Bleeding (hemorrhage)
  • Changes in kidney function blood tests
  • Dry eye
  • Abnormal blood clotting test results
  • Diarrhea
  • Rash

Your healthcare provider may decrease your dose of TIVDAK, temporarily stop, or completely stop treatment if you have side effects.

What should I tell my healthcare provider before receiving TIVDAK?

Tell your healthcare provider about all your medical conditions, including if you:

  • have a history of vision or eye problems
  • have numbness or tingling in your hands or feet
  • have bleeding problems
  • have liver problems
  • are pregnant or plan to become pregnant, TIVDAK can harm your unborn baby.
  • are breastfeeding (nursing) or plan to breastfeed. It is not known if TIVDAK passes into your breast milk. Do not breastfeed during treatment and for at least 3 weeks after the last dose of TIVDAK

    Females who are able to become pregnant:

    • Your healthcare provider should do a pregnancy test before you start treatment with TIVDAK.
    • You should use an effective method of birth control during your treatment and for at least 2 months after the last dose of TIVDAK.

    Males with female partners who are able to become pregnant:

    • You should use effective birth control during treatment and for 4 months after the last dose of TIVDAK

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

These are not all the possible side effects of TIVDAK. Discuss side effects with your healthcare provider. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch or call 1-800-FDA-1088.

Please see Important Facts about TIVDAK including IMPORTANT WARNING.

Select Important
Safety Information


What is the most important information I should know about TIVDAK?

Eye problems are common with TIVDAK and can be serious. TIVDAK can cause changes to the surface of your eye that can lead to dry eyes, eye redness, eye irritation, corneal ulcers, blurred vision, and severe vision loss.

You are now leaving
tivdak.com